medigraphic.com
ISSN 2221-2434 (Electronic)

2013, Number 4

<< Back Next >>

Finlay 2013; 3 (4)

Choroidal melanoma with axillary metastasis. A case report

Torres AL, Fraga SO

Language: Spanish
References: 19
Page: 255-258
PDF size: 154.27 Kb.


ABSTRACT

Choroidal melanoma is the most common intraocular tumor among adults. Its global incidence is low, 6 cases per 1 million population, but it has a high degree of malignancy and propensity for metastasis. We report the case of a female patient aged 34 years with a history of having the right eye enucleated 14 years earlier due to a choroidal melanoma. She was treated at the Dr. Gustavo Aldereguía Lima University General Hospital in Cienfuegos for metastasis to the left axilla. The publication of this case was considered relevant to health professionals because of the rarity of this disease, and the long survival of the patient, without systemic treatment, after the enucleation of the affected eye.


REFERENCES

  1. Fisher D, Kwong L, Chin L. Melanoma. In: DeVita VT Jr, Lawrence TS, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology. 8th. ed. Philadelphia: Lippincott Williams and Wilkins; 2008. p. 1889-1966.

  2. Alonso J, Pérez T, González JR. Melanoma cutáneo con metástasis gástrica. Presentación de un caso. Medisur [revista en Internet]. 2012 [ cited 24 Mar 2013 ] ; 10 (5): [aprox. 5p]. A v a i l a b l e f r o m : http://www.medisur.sld.cu/index.php/medisur/arti cle/view/1807.

  3. Stephen B, Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Annals of Surgical Oncology. 2010 ; 17 (6): 1471-4.

  4. Díaz A, Lara MA, Ortega P, Aramendi T, González C, Alberdi JM, et al. Melanoma colorrectal: revisión de dos formas diferentes de presentación. Gastroenterol Hepatol. 2011 ; 34 (2): 83-8.

  5. Melgares MA, Santos D, Puig M, Cruz J, Mesa E, Cordiés N. Melanoma de coroides. Estudio de la casuística en el INOR en el período de 1980–1996. Rev Cubana Oncol. 1998 ; 14 (3): 149-54.

  6. Castro IC, Rodríguez M, Ruíz M, Díaz E. Melanoma coroideo: a propósito de 3 casos. Gaceta Médica Espirituana. 2011 ; 13 (3): 1-8.

  7. Infante Y, Cabeza E, Pina M, Peral I. Melanoma de coroides. Presentación de un caso clínico. Gaceta Médica Espirituana. 2011 ; 13 (1): 1-10.

  8. Rodríguez A, Gallardo L, Chávez I, Borrego X. Melanoma de coroides: presentación de un caso. AMC. 2012 ; 16 (3): 310-7.

  9. O’Day SJ, Atkins MB, Boasberg P, Wang HJ, Thompson JA, Anderson CM, et al. Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma. J Clin Oncol. 2009 ; 27 (36): 6207-12.

  10. Gupta V, Gupta A. Intraocular Tumors. Atlas Optical Coherence Tomography of Macular Diseases and Glaucoma. 2006 ; 22: 405-7.

  11. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006 ; 355 (13): 1307-17.

  12. Blanco C, Capeáns C, Otero XL. Calidad de vida en pacientes con melanoma de coroides. Arch Soc Esp Oftalmol. 2008 ; 83 (5): 301-6.

  13. Coloma J, García E. Mengual V. El melanoma ocular y su tratamiento. Annals d’ Oftalmología. 2007 ; 15 (3): 147-54.

  14. Eggermont AM, Suciu S, Santinami M, Testori A, Kruit WH, Marsden J, et al. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet. 2008 ; 372 (9633): 117-26.

  15. Dudley ME, Yang JC, Sherry R, Hughes MS, Royal R, Kammula U, et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J Clin Oncol. 2008 ; 26 (32): 5233-9.

  16. Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010 ; 363 (8): 711-23.

  17. Ives NJ, Stowe RL, Lorigan P, Wheatley K. Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients. J Clin Oncol. 2007 ; 25 (34): 5426-34.

  18. Hauschild A, Agarwala SS, Trefzer U, Hogg D, Robert C, Hersey P, et al. Results of a phase III randomized placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma. J Clin Oncol. 2009 ; 27 (17): 2823-30.

  19. Flaherty KT, Lee SJ, Zhao F, Schuchter LM, Flaherty L, Kefford R, et al. Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanoma. J Clin Oncol. 2013 ; 31 (3): 373-9.




2020     |     www.medigraphic.com